Equillium Inc (EQ)
0.711
-0.01
(-1.25%)
USD |
NASDAQ |
Nov 22, 16:00
0.7306
+0.02
(+2.76%)
After-Hours: 20:00
Equillium Revenue (Annual): 36.08M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 36.08M |
Date | Value |
---|---|
December 31, 2022 | 15.76M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
15.76M
Minimum
2022
36.08M
Maximum
2023
25.92M
Average
25.92M
Median
Revenue (Annual) Benchmarks
Matinas BioPharma Holdings Inc | 1.096M |
Tenon Medical Inc | 2.928M |
Alphatec Holdings Inc | 482.26M |
Madrigal Pharmaceuticals Inc | -- |
Spero Therapeutics Inc | 96.74M |